Q1 of 2023 is my guess. As far as the SP goes I do
Post# of 148165
(Total Views: 642)
Posted On: 12/08/2022 11:44:57 AM
Q1 of 2023 is my guess. As far as the SP goes I do expect a to be higher after the hold but do I think it enough for us to raise money for a NASH trial with all the debt we have to pay as well… Nope.
Q3 of 2023 NASH trial starts. So the hold will be lifted before that.
With all of that being said. Listen to the last two minutes of the last CC. It’s in my opinion that the money isn’t coming from private or even public placement next year. Maybe we get some more funding for two more months from private placement but I’m assuming that will stop sooner than later.
Sounds like we are searching or still have a partner for NASH for 2023. That’s why our focus is on NASH. Don’t listen to the soft basher about saying there is no partnership in the works or that it won’t ever happen. It isn’t uncommon at all for small bio companies to partner with big pharma. It’s actually common and that’s where funding would take place.
Cyrus is pretty clear towards the end of the CC as to what the plan will be for 2023. 2022 was cleaning house. I believe Kelly won’t be with us much longer as well.
Remember the basher have been claiming bankruptcy and other crazy things for over a year. Do not trust them. Many of them are upset they lost a ton of money from Bruce Patterson. I know who all of them are by name. None of them can be trusted.
We are in good hands. The price will reflect that hopefully within the next 6 months is my guess.
Q3 of 2023 NASH trial starts. So the hold will be lifted before that.
With all of that being said. Listen to the last two minutes of the last CC. It’s in my opinion that the money isn’t coming from private or even public placement next year. Maybe we get some more funding for two more months from private placement but I’m assuming that will stop sooner than later.
Sounds like we are searching or still have a partner for NASH for 2023. That’s why our focus is on NASH. Don’t listen to the soft basher about saying there is no partnership in the works or that it won’t ever happen. It isn’t uncommon at all for small bio companies to partner with big pharma. It’s actually common and that’s where funding would take place.
Cyrus is pretty clear towards the end of the CC as to what the plan will be for 2023. 2022 was cleaning house. I believe Kelly won’t be with us much longer as well.
Remember the basher have been claiming bankruptcy and other crazy things for over a year. Do not trust them. Many of them are upset they lost a ton of money from Bruce Patterson. I know who all of them are by name. None of them can be trusted.
We are in good hands. The price will reflect that hopefully within the next 6 months is my guess.
(12)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼